TERESA JENKINS-MCCORD: Open Payments
NPI 1538160379 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,532 in 67 payments from 17 companies in 2025. Trend: 2023 $2,112 · 2024 $2,265 · 2025 $2,532
Food & beverage: $2,399Education: $133
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $538 |
| Regeneron Healthcare Solutions, Inc. | 10 | $419 |
| GENZYME CORPORATION | 5 | $231 |
| GlaxoSmithKline, LLC. | 6 | $209 |
| Pharming Healthcare, Inc. | 4 | $201 |
| Viatris Specialty LLC | 4 | $194 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $180 |
| Genentech USA, Inc. | 4 | $118 |
| Blueprint Medicines Corporation | 2 | $79 |
| Amgen Inc. | 3 | $70 |
Products named: DUPIXENT, NUCALA, RUCONEST, YUPELRI, NEFFY, TEZSPIRE, BREZTRI, Xolair.
Industry payments across NM — which companies pay providers there.
